Related Experiment Video
Updated: Jul 2, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free
Lassi Luomala1, Kalle Mattila2,3, Paula Vainio4
1Dept. of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Nuclear expression of PHD2 and PHD3 proteins indicates better outcomes for clear cell renal cell carcinoma (ccRCC) patients. These hypoxia-inducible factor regulators are promising biomarkers for predicting ccRCC recurrence-free survival.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Hypoxia-inducible factors (HIFs) and their regulators, prolyl hydroxylase domain proteins (PHDs), are crucial in cellular responses to hypoxia.
- These factors play a role in clear cell renal cell carcinoma (ccRCC) progression.
- PHD biomarkers may enhance predictions of disease progression and guide adjuvant treatment decisions for ccRCC.
Purpose of the Study:
- To investigate the association of PHD2 and PHD3 expression with histopathological features and recurrence-free survival (RFS) in localized ccRCC.
- To evaluate PHD2 and PHD3 as potential prognostic biomarkers in ccRCC.
Main Methods:
- Retrospective analysis of 173 patients with localized ccRCC from Helsinki University Hospital (HUH).
- External validation using a cohort of 191 patients from Turku University Hospital (TUH).
- Immunohistochemical staining of tissue microarrays to assess nuclear and cytoplasmic expression of PHD2 and PHD3, correlated with clinical and histopathological data.
Main Results:
- Nuclear expression of PHD2 and PHD3 was associated with lower tumor stage (pT-stage) and Fuhrman grade.
- Patients with positive nuclear PHD2 and PHD3 expression showed favorable RFS compared to those with negative expression.
- Nuclear PHD2 expression independently predicted a reduced risk of disease recurrence or death in multivariable analysis, consistent across both cohorts.
Conclusions:
- Absence of nuclear PHD2 and PHD3 expression in ccRCC correlates with poor RFS.
- Nuclear PHD2 expression is a significant predictor of RFS, independent of other prognostic factors.
- Nuclear PHD2 and PHD3 represent potential prognostic biomarkers for localized ccRCC, warranting further prospective validation.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cell Specific Gene Expression
The Nucleolus
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

